Evinova's globally scaled digital healthcare solutions are evidence-based, science-based and human-experience-based, serving clinical trial sponsors, clinical research organizations (CROs), clinical trial site care teams and patients.
AstraZeneca launched Evinova, which aims to become a leading provider of digital healthcare solutions to better meet the needs of healthcare professionals, regulators and...
New solutions empower clinicians and research teams with AI orchestration, model development, visualization, and multi-modal data management to power clinical research, clinical trials, and patient care strategies.
ConcertAI's TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in-category capabilities in advanced visualization, AI, and expansions to its AI partner ecosystem to...
Cofactor Genomics, the company bridging the precision medicine gap, announced successful validation of the OncoPrism immunotherapy predictive diagnostic assay, enabling physicians to use the test to help guide treatment decisions for patients with metastatic or recurrent squamous cell carcinoma of the head and neck (HNSCC). The successful readout is...
TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, is proud to announce that its innovative Product Availability Intelligence (PAI) solution has been recognized with a Bronze award by the prestigious Merit...
ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced the addition of Lucida Medical to its Eureka Clinical AI Platform ecosystem. It will be deployed within the UK's National Health Service (NHS) and European healthcare systems.
Pi™ (Prostate Intelligence™), Lucida Medical's AI-machine learning software, is designed to help...
Generate:Biomedicines announced a publication in Nature describing Chroma, a generative AI model that can program novel proteins not previously found in nature with targeted biophysical, biological, and therapeutic properties. Along with this announcement, the company is making the model available to the broader research community with the goal of accelerating...
Dose-escalation study to evaluate ORB-011 as single agent, with initial safety, pharmacokinetic and mechanism-based pharmacodynamic readouts
Orionis Biosciences, a life sciences company pioneering the creation of highly selective and tunable therapeutics for cancer and other diseases, announced that the first patient has been dosed in a Phase 1 clinical trial...
Charles River Laboratories International, Inc. and Aitia, a leader in the application of Causal AI and Digital Twins, announced a strategic agreement that gives Aitia access to Logica™, Charles River's Artificial Intelligence (AI) powered drug solution platform, for the optimized discovery and early development of multiple therapeutic programs for neurodegenerative disease and...
Code Ocean, the world's first Reproducible Research Cloud, announced that it has been selected as a winner of the 2023 BioTech Breakthrough Awards in the category of "QC Data Management Solution of the Year."
Code Ocean provides the first and only integrated library and workbench that guarantees reproducibility and speeds up...
VeriSIM Life announces recognition for continued advances with BIOiSIM, a first-in-class virtual drug development engine.
VeriSIM Life— the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development— announced that it has once again been named "Predictive Analytics Solution of the Year" at the 2023 BioTech Breakthrough Awards....
